Thứ năm, 14/10/2021 23:49 GMT+7

Các bài nghiên cứu mới về COVID-19 từ ngày 01/10 đến ngày 08/10/2021

Cục Thông tin KH&CN quốc gia trân trọng kính gửi đến các nhà khoa học những nghiên cứu mới nhất về COVID-19 trên thế giới. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống từ ngày 01/10 đến ngày 08/10/2021. Những nghiên cứu công bố trước thời gian này được tổng hợp tại đường link cuối bài.

SCIENCEDIRECT

 

1. Unmethylated CpG motif-containing genomic DNA fragments of bacillus calmette-guerin improves immune response towards a DNA vaccine for COVID-19

Vaccine, 3 September 2021, Volume 39, Issue 41, Pages 6050-6056

Zehua Zhou, Xinyu Zhang, Weijin Huang

https://www.sciencedirect.com/science/article/pii/S0264410X21011658/pdfft?md5=5db7a91fe736398c5431c17309f4e91d&pid=1-s2.0-S0264410X21011658-main.pdf

 

2. Immunological evaluation of an inactivated SARS-CoV-2 vaccine in rhesus macaques

Molecular Therapy - Methods & Clinical Development, 26 August 2021, Volume 23, Pages 108-118

Hongbo Chen, Zhongping Xie, Qihan Li

https://www.sciencedirect.com/science/article/pii/S2329050121001315/pdfft?md5=cb38ccef2823839c17fa2ac427563fc8&pid=1-s2.0-S2329050121001315-main.pdf

 

3. Gene expression profiling of corona virus microarray datasets to identify crucial targets in COVID-19 patients

Gene Reports, 27 November 2020, Volume 22 (Cover date: March 2021), Article 100980

Priyanka Ramesh, Shanthi Veerappapillai, Ramanathan Karuppasamy

https://www.sciencedirect.com/science/article/pii/S2452014420303940

 

4. Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment

ESMO Open, 8 September 2021, Volume 6, Issue 5,Article 100274

M. Peeters, L. Verbruggen, P. van Dam

https://www.sciencedirect.com/science/article/pii/S2059702921002362/pdfft?md5=5fcafef5c34679a0ab2ba414d413a760&pid=1-s2.0-S2059702921002362-main.pdf

 

5. Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)

Volume 99, Issue 4 (Cover date: April 2021), Article 115294

Emelissa J. Valcourt, Kathy Manguiat, Heidi Wood

https://www.sciencedirect.com/science/article/pii/S0732889320306714/pdfft?md5=b521b4dbfda14f1862b7e0d07e7d3c0c&pid=1-s2.0-S0732889320306714-main.pdf

 

6. Origin, phylogeny, variability and epitope conservation of SARS-CoV-2 worldwide

Virus Research, 30 July 2021, Volume 304, Article 198526

Filipa F. Vale, Jorge M. B. Vítor, Joao Goncalves

https://www.sciencedirect.com/science/article/pii/S0168170221002331/pdfft?md5=ce2869f091f3bc795ebbd6b6b923fddf&pid=1-s2.0-S0168170221002331-main.pdf

7. Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected

Journal of Infection, 25 July 2021, Volume 83, Issue 4, Pages 467-472

Anna Gidari, Samuele Sabbatini, Daniela Francisci

https://www.sciencedirect.com/science/article/pii/S0163445321003625/pdfft?md5=02f81b73c37052f3fb7934226511858a&pid=1-s2.0-S0163445321003625-main.pdf

 

8. Programmed −1 Ribosomal Frameshifting in coronaviruses: A therapeutic target

Virology, 25 December 2020, Volume 554 (Cover date: February 2021), Pages 75-82

Jamie A. Kelly, Michael T. Woodside, Jonathan D. Dinman

https://www.sciencedirect.com/science/article/pii/S0042682220302506/pdfft?md5=1d7c38458cbd28c5c5b17ab020622a27&pid=1-s2.0-S0042682220302506-main.pdf

 

9. A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19

Molecular Therapy, 14 May 2021, Volume 29, Issue 7, Pages 2219-2226

Adi Idris, Alicia Davis, Kevin V. Morris

https://www.sciencedirect.com/science/article/pii/S1525001621002562/pdfft?md5=5eccf8706ece4088476996b969eab98b&pid=1-s2.0-S1525001621002562-main.pdf

 

10. Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients

American Journal of Kidney Diseases, 24 June 2021, Volume 78, Issue 4, Pages 571-581

José Jesús Broseta, Diana Rodríguez-Espinosa, Francisco Maduell

https://www.sciencedirect.com/science/article/pii/S0272638621006892/pdfft?md5=9b67f3d27d76a88aa6792c386e020ee9&pid=1-s2.0-S0272638621006892-main.pdf

 

11. Pathophysiology and pharmacological management of pulmonary and cardiovascular features of COVID-19

Journal of Molecular and Cellular Cardiology, 26 December 2020,

Volume 153 (Cover date: April 2021), Pages 72-85

https://www.sciencedirect.com/science/article/pii/S0022282820303497/pdfft?md5=f67edca1848b5b8b3341aa7d336e5ea2&pid=1-s2.0-S0022282820303497-main.pdf

 

12. Dual targeting of 3CLpro and PLpro of SARS-CoV-2: A novel structure-based design approach to treat COVID-19

Current Research in Structural Biology, 10 December 2020, Volume 3 (Cover date: 2021), Pages 9-18

Sajjan Rajpoot, Manikandan Alagumuthu, Mirza S. Baig

https://www.sciencedirect.com/science/article/pii/S2665928X20300258/pdfft?md5=940a18de0bfe3981630bf273b24651b8&pid=1-s2.0-S2665928X20300258-main.pdf

 

13. Molecular insight into the genomic variation of SARS-CoV-2 strains from current outbreak

Computational Biology and Chemistry, 18 June 2021, Volume 93, Article 107533

Avizit Das, Sarah Khurshid, Fee Faysal Ahmed

https://www.sciencedirect.com/science/article/pii/S1476927121001006/pdfft?md5=e0437ba03b892004679083bbba5e6b8d&pid=1-s2.0-S1476927121001006-main.pdf

 

14. Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2

Journal of Virological Methods, 14 October 2020, Volume 287 (Cover date: January 2021), Article 113995

Jun-Gyu Park, Fatai S. Oladunni, Luis Martinez-Sobrido

https://www.sciencedirect.com/science/article/pii/S0166093420302470/pdfft?md5=de1ec0e64bd78d89f497dd92f613104e&pid=1-s2.0-S0166093420302470-main.pdf

 

15. Quantification of SARS-CoV-2 spike and nucleocapsid proteins using isotope dilution tandem mass spectrometry

Vaccine, 24 July 2021, Volume 39, Issue 36, Pages 5106-5115

Carrie Pierce-Ruiz, Wanda I. Santana, Tracie L. Williams

https://www.sciencedirect.com/science/article/pii/S0264410X21009592/pdfft?md5=88974987b57a132102a1978d6dbc935a&pid=1-s2.0-S0264410X21009592-main.pdf

 

16. Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach

Journal of Traditional and Complementary Medicine, 4 January 2021, Volume 11, Issue 2, Pages 158-172

Panthakarn Rangsinth, Chanin Sillapachaiyaporn, Siriporn Chuchawankul

https://www.sciencedirect.com/science/article/pii/S2225411021000018/pdfft?md5=4542bc672e66bf34a592e5400becb332&pid=1-s2.0-S2225411021000018-main.pdf

 

17. Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2

Cell Reports, 26 January 2021, Volume 34, Issue 7, Article 108737

Timothy A. Bates, Jules B. Weinstein, Fikadu G. Tafesse

https://www.sciencedirect.com/science/article/pii/S2211124721000504/pdfft?md5=bb275cb800a30dbb7250872ac6e7f0b0&pid=1-s2.0-S2211124721000504-main.pdf

 

18. Humoral response to SARS-CoV-2 COVID-19 vaccines in patients with multiple sclerosis treated with immune reconstitution therapies

Multiple Sclerosis and Related Disorders, 15 July 2021, Volume 54, Article 103150

Jelena Drulovic, Jovana Ivanovic, Tatjana Pekmezovic

https://www.sciencedirect.com/science/article/pii/S221103482100417X/pdfft?md5=70ea6339191e4fd87e316f83277ab633&pid=1-s2.0-S221103482100417X-main.pdf

 

19. Spontaneous binding of potential COVID-19 drugs (Camostat and Nafamostat) to human serine protease TMPRSS2

Computational and Structural Biotechnology Journal, 28 December 2020, Volume 19 (Cover date: 2021), Pages 467-476

Haixia Zhu, Wenhao Du, Qiang Huang

https://www.sciencedirect.com/science/article/pii/S2001037020305602/pdfft?md5=b2887c9215f6fe9a985b375f6b0e4435&pid=1-s2.0-S2001037020305602-main.pdf

 

20. Therapeutic perceptions in antisense RNA-mediated gene regulation for COVID-19

Gene, 16 July 2021, Volume 800, Article 145839

Sabrina Ferreira de Jesu, sLaércio Ives Santos, André Luiz Sena Guimaraes

https://www.sciencedirect.com/science/article/pii/S0378111921004340/pdfft?md5=15b89e0843c28c24ce78c798a411c51b&pid=1-s2.0-S0378111921004340-main.pdf

 

21. Comparative analysis of antibodies to SARS-CoV-2 between asymptomatic and convalescent patients

iScience, 1 May 2021, Volume 24, Issue 6, Article 102489

Connor J. Dwyer, Colleen A. Cloud, Shikhar Mehrotra

https://www.sciencedirect.com/science/article/pii/S2589004221004570/pdfft?md5=4ccf3a878e8d62d8f9d1e61b43c99724&pid=1-s2.0-S2589004221004570-main.pdf

 

22. D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction

Cell Reports, 26 December 2020, Volume 34, Issue 2 (Cover date: 12 January 2021), Article 108630

Sophie M. -C. Gobeil, Katarzyna Janowska, Priyamvada Acharya

https://www.sciencedirect.com/science/article/pii/S2211124720316193/pdfft?md5=2ab0498de58c3a8c45737114e3755618&pid=1-s2.0-S2211124720316193-main.pdf

 

23. Serological analysis reveals an imbalanced IgG subclass composition associated with COVID-19 disease severity

Cell Reports Medicine, 15 June 2021, Volume 2, Issue 7, Article 100329

Jennifer L. Yates, Dylan J. Ehrbar, William T. Lee

https://www.sciencedirect.com/science/article/pii/S2666379121001725/pdfft?md5=6a8dda4270d32ef7cc15cdf93aff9fa1&pid=1-s2.0-S2666379121001725-main.pdf

 

24. Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species

Immunity, 8 June 2021, Volume 54, Issue 7, Pages 1611-1621.e5

Ruoke Wang, Qi Zhang, Linqi Zhang

https://www.sciencedirect.com/science/article/pii/S1074761321002478/pdfft?md5=b54b25fb60378ed257dcdf1112249413&pid=1-s2.0-S1074761321002478-main.pdf

 

25. Pinpointing the potential hits for hindering interaction of SARS-CoV-2 S-protein with ACE2 from the pool of antiviral phytochemicals utilizing molecular docking and molecular dynamics (MD) simulations

Journal of Molecular Graphics and Modelling, 22 February 2021, Volume 105, Article 107874

Chirag N. Patel, Dweipayan Goswami, Himanshu A. Pandya

https://www.sciencedirect.com/science/article/pii/S1093326321000437/pdfft?md5=8a0e22ac074b245f55d151fc1843700e&pid=1-s2.0-S1093326321000437-main.pdf

 

26. A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence

Cell, 23 February 2021, Volume 184, Issue 8, Pages 2229-2238.e13

Xianwen Zhang, Yang Liu, Pei-Yong Shi

https://www.sciencedirect.com/science/article/abs/pii/S0092867421002336

 

27. Single-step, wash-free digital immunoassay for rapid quantitative analysis of serological antibody against SARS-CoV-2 by photonic resonator absorption microscopy

Talanta, 14 December 2020, Volume 225 (Cover date: 1 April 2021), Article 122004

Bin Zhao, Congnyu Che, Brian T. Cunningham

https://www.sciencedirect.com/science/article/pii/S0039914020312959/pdfft?md5=c1a3ee5795c32dc8e70c1d63d478d1f5&pid=1-s2.0-S0039914020312959-main.pdf

 

28. One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening

Cell Reports, 10 August 2021, Volume 36, Issue 9, Article 109627

Irene M. Francino-Urdaniz, Paul J. Steiner, Timothy A. Whitehead

https://www.sciencedirect.com/science/article/pii/S2211124721010652/pdfft?md5=d0985c65abc64a21723eb9cf45254332&pid=1-s2.0-S2211124721010652-main.pdf

 

29. Berries anthocyanins as potential SARS-CoV–2 inhibitors targeting the viral attachment and replication; molecular docking simulation

Egyptian Journal of Petroleum, 21 January 2021, Volume 30, Issue 1, Pages 33-43

Omar Messaoudi, Hicham Gouzi, Mourad Bendahou

https://www.sciencedirect.com/science/article/pii/S1110062121000015/pdfft?md5=137f275166bb4f54182c65c385e7f014&pid=1-s2.0-S1110062121000015-main.pdf

 

30. Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples

Journal of Immunological Methods, 28 November 2020, Volume 489 (Cover date: February 2021), Article 112937

Livia Mazzini, Donata Martinuzzi, Emanuele Montomoli

https://www.sciencedirect.com/science/article/pii/S0022175920302313/pdfft?md5=d7ccc1c6479ff5c6056b8d41ef4d7250&pid=1-s2.0-S0022175920302313-main.pdf

 

31. Dynamics of B cell repertoires and emergence of cross-reactive responses in patients with different severities of COVID-19

Cell Reports, 9 May 2021, Volume 35, Issue 8, Article 109173

Zachary Montague, Huibin Lv, Chris Ka Pun Mok

https://www.sciencedirect.com/science/article/pii/S2211124721005180/pdfft?md5=670414faef1503a8578b5e2415146681&pid=1-s2.0-S2211124721005180-main.pdf

 

32. Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals

EBioMedicine, 6 October 2021, Volume 72,Article 103610

Isaac Quiros-Fernandez, Mansour Poorebrahim, Angel Cid-Arregui

https://www.sciencedirect.com/science/article/pii/S2352396421004035/pdfft?md5=5a39f126e8ab7b0c8d151b0e20bb3675&pid=1-s2.0-S2352396421004035-main.pdf

 

33. In vitro cell culture model of human nasal-associated lymphoid tissue (NALT) to evaluate the humoral immune response to SARS-CoV-2 spike proteins

Saudi Journal of Biological Sciences, 24 April 2021, Volume 28, Issue 8, Pages 4516-4521

Waleed H. Mahallawi, Talal M. Aljeraisi

https://www.sciencedirect.com/science/article/pii/S1319562X21003144/pdfft?md5=7ec87930715eaf5ed25e4b59bbccfc6a&pid=1-s2.0-S1319562X21003144-main.pdf

 

34. Rapid and sensitive triple-mode detection of causative SARS-CoV-2 virus specific genes through interaction between genes and nanoparticles

Analytica Chimica Acta, 17 February 2021, Volume 1154, Article 338330

Yakun Gao, Yingkuan Han, Yu Zhang

https://www.sciencedirect.com/science/article/pii/S0003267021001562/pdfft?md5=6125bb3f0266f095c0bef9e239896e8b&pid=1-s2.0-S0003267021001562-main.pdf

 

35. In silico validation of potent phytochemical orientin as inhibitor of SARS-CoV-2 spike and host cell receptor GRP78 binding

Heliyon, 11 January 2021, Volume 7, Issue 1, Article e05923

Arijit Bhowmik, Souradeep Biswas, Prosenjit Saha

https://www.sciencedirect.com/science/article/pii/S2405844021000281/pdfft?md5=ecc1fa35849dd3fff93634c695525d0f&pid=1-s2.0-S2405844021000281-main.pdf

 

36. Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals

Cell Reports, 10 August 2021, Volume 36, Issue 8, Article 109604

Elaine C. Chen, Pavlo Gilchuk, James E. Crowe

https://www.sciencedirect.com/science/article/pii/S2211124721010421/pdfft?md5=a31e0f0e117b2916c7f75f0808dc0f6a&pid=1-s2.0-S2211124721010421-main.pdf

 

37. Computational design of SARS-CoV-2 spike glycoproteins to increase immunogenicity by T cell epitope engineering

Computational and Structural Biotechnology Journal, 31 December 2020, Volume 19 (Cover date: 2021), Pages 518-529

Edison Ong, Xiaoqiang Huang, Yongqun He

https://www.sciencedirect.com/science/article/pii/S200103702030564X/pdfft?md5=58bb83e20ddd47d6eaa97aba7774ebde&pid=1-s2.0-S200103702030564X-main.pdf

 

38. The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis

Kidney International, 18 July 2021, Volume 100, Issue 4, Pages 928-936

Maxime Espi, Xavier Charmetant, Olivier Thaunat

https://www.sciencedirect.com/science/article/pii/S0085253821006797/pdfft?md5=23e7967e0882b5126000e6071f180c6e&pid=1-s2.0-S0085253821006797-main.pdf

 

39. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19

Cell, 23 November 2020, Volume 184, Issue 1 (Cover date: 7 January 2021), Pages 169-183.e17

Lauren B. Rodda, Jason Netland, Marion Pepper

https://www.sciencedirect.com/science/article/abs/pii/S0092867420315658

 

40. Elucidation of interactions regulating conformational stability and dynamics of SARS-CoV-2 S-protein

Biophysical Journal, 21 January 2021, Volume 120, Issue 6, Pages 1060-1071

Takaharu Mori, Jaewoon Jung, Yuji Sugita

https://www.sciencedirect.com/science/article/pii/S0006349521000497/pdfft?md5=d92cb54d84991926d3fd7ff7ac04a9b9&pid=1-s2.0-S0006349521000497-main.pdf

 

41. Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting

Clinical Microbiology and Infection, 14 October 2020, Volume 27, Issue 3 (Cover date: March 2021), Pages 469.e9-469.e15

Jordan P. Skittrall, Michael Wilson, Hamid Jalal

https://www.sciencedirect.com/science/article/abs/pii/S1198743X20306145

 

42. In silico study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking tools

Computers in Biology and Medicine, 28 August 2021, Volume 137, Article 104818

Anish Nag, Subhabrata Paul, Rita Kundu

https://www.sciencedirect.com/science/article/pii/S0010482521006120/pdfft?md5=d493bcac3e2cf6d8c40974c9dbc8c982&pid=1-s2.0-S0010482521006120-main.pdf

 

43.  Mucosal IgA response elicited by intranasal immunization of Lactobacillus plantarum expressing surface-displayed RBD protein of SARS-CoV-2

International Journal of Biological Macromolecules, 7 September 2021, Volume 190, Pages 409-416

Letian Li, Maopeng Wang, Chang Li

https://www.sciencedirect.com/science/article/pii/S0141813021019097/pdfft?md5=11e140883c1ade89442585042f07dc4f&pid=1-s2.0-S0141813021019097-main.pdf

 

44. Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity

Virology, 11 September 2021, Volume 563, Pages 134-145

Shang Yu Gong, Debashree Chatterjee, Andrés Finzi

https://www.sciencedirect.com/science/article/pii/S0042682221001860/pdfft?md5=0f59b06e9d6e2601207fbd4604e0dece&pid=1-s2.0-S0042682221001860-main.pdf

 

45. Genomic evidence for reinfection with SARS-CoV-2: a case study

The Lancet Infectious Diseases, 12 October 2020, Volume 21, Issue 1 (Cover date: January 2021), Pages 52-58

Richard L Tillett, Joel R Sevinsky, Mark Pandori

https://www.sciencedirect.com/science/article/pii/S1473309920307647/pdfft?md5=eb76e7b56e0bf5162450238eb0ed93cf&pid=1-s2.0-S1473309920307647-main.pdf

 

46. Molecular designing, crystal structure determination and in silico screening of copper(II) complexes bearing 8-hydroxyquinoline derivatives as anti-COVID-19

Bioorganic Chemistry, 24 February 2021, Volume 110, Article 104772

Arif Ali, Nasim Sepay, Musheer Ahmad

https://www.sciencedirect.com/science/article/pii/S0045206821001498/pdfft?md5=2e5bebc97c83c1f240a807f883d09785&pid=1-s2.0-S0045206821001498-main.pdf

 

47. Revealing the Threat of Emerging SARS-CoV-2 Mutations to Antibody Therapies

Journal of Molecular Biology, 14 July 2021, Volume 433, Issue 18, Article 167155

Jiahui Chen, Kaifu Gao, Guo-Wei Wei

https://www.sciencedirect.com/science/article/pii/S0022283621003843/pdfft?md5=afbd0e887b4ceb8194c619e1a3006737&pid=1-s2.0-S0022283621003843-main.pdf

 

48. Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis

iScience, 2 September 2021, Volume 24, Issue 9, Article 103078

Klara Asplund Högelin, Nicolas Ruffin, Faiez Al Nimer

https://www.sciencedirect.com/science/article/pii/S2589004221010464/pdfft?md5=51dc7a36d39c6201091f698f992e1989&pid=1-s2.0-S2589004221010464-main.pdf

 

49. Bioinformatics prediction of B and T cell epitopes within the spike and nucleocapsid proteins of SARS-CoV2

Journal of Infection and Public Health, 15 December 2020, Volume 14, Issue 2 (Cover date: February 2021), Pages 169-178

Reham M. Dawood, Mai A. El-Meguid, Mostafa K. El Awady

https://www.sciencedirect.com/science/article/pii/S1876034120307620/pdfft?md5=42a23666c64f0a09d38cd64858ee6c52&pid=1-s2.0-S1876034120307620-main.pdf

 

50. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

The Lancet Infectious Diseases, 17 November 2020, Volume 21, Issue 2 (Cover date: February 2021), Pages 181-192

Yanjun Zhang, Gang Zeng, Fengcai Zhu

https://www.sciencedirect.com/science/article/pii/S1473309920308434/pdfft?md5=72aee1b11caaa620b930d87157b9a2ba&pid=1-s2.0-S1473309920308434-main.pdf

 

WILEY:

 

1. Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID-19

Anna Lee, Chung Hyun Nahm, Jin-Soo Lee, Mi-Kyeong Lee, Kyoung-Ryul Lee

Journal of Clinical Laboratory Analysis

First published: 05 October 2021                                               

https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcla.24004

 

2. A Modular Biomaterial Scaffold-Based Vaccine Elicits Durable Adaptive Immunity to Subunit SARS-CoV-2 Antigens

Fernanda Langellotto, Maxence O. Dellacherie, Chyenne Yeager, Hamza Ijaz, Jingyou Yu, Chi-An Cheng, Nikolaos Dimitrakakis, Benjamin T. Seiler, Makda S. Gebre, Tal Gilboa, Rebecca Johnson, Nadia Storm, Sarai Bardales, Amanda Graveline, Des White, Christina M. Tringides, Mark J. Cartwright, Edward J. Doherty, Anna Honko, Anthony Griffiths, Dan H. Barouch, David R. Walt, David J. Mooney

Advanced Healthcare Materials

First published: 04 October 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1002/adhm.202101370

 

3. Histological findings of tracheal samples from COVID-19 positive critically ill mechanically ventilated patients

P.A. Ward, J. Collier, J. Weir, M. Osborn, B. Hanley, W.J.B. Smellie, Chelwest COVID-19 Tracheostomy Group

Clinical Otolaryngology

First published: 04 October 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1111/coa.13872

 

4. Predictive role of FAR ratio in Covid-19 patients

Deniz Çekiç, Mehmet Emir Arman, Ahmed Cihad Genç, Kubilay İşsever, İlhan Yıldırım, Ahmed Bilal Genç, Hamad Dheir, Selçuk Yaylacı

International Journal of Clinical Practice

First published: 04 October 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1111/ijcp.14931

 

5. Gamma-glutamyl-transferase may predict COVID-19 outcomes in hospitalized patients

Benan Kasapoglu, Ahmet Yozgat, Alpaslan Tanoglu, Guray Can, Yusuf Serdar Sakin, Murat Kekilli

International Journal of Clinical Practice

First published: 04 October 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1111/ijcp.14933

 

6.  Post-infection pulmonary sequelae after COVID-19 among patients with lung transplantation

Luke D. Mahan, Isaac Lill, Quinn Halverson, Manish R. Mohanka, Adrian Lawrence, John Joerns, Srinivas Bollineni, Vaidehi Kaza, Ricardo M. La Hoz, Song Zhang, Corey D. Kershaw, Lance S. Terada, Fernando Torres, Amit Banga

Transplant Infectious Disease

First published: 04 October 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1111/tid.13739

 

7.  Antibody response to two doses of inactivated SARS-CoV-2 vaccine (CoronaVac) in Kidney Transplant Recipients

Rezzan Eren Sadioğlu, Erol Demir, Ebru Evren, Merve Aktar, Seda Şafak, Ayşe Serra Artan, Sevim Meşe, Ali Ağaçfidan, Güle Çınar, Mustafa Önel, Zeynep Ceren Karahan, Şule Şengül, Kenan Keven, Aydın Türkmen

Transplant Infectious Disease

First published: 04 October 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1111/tid.13740

 

8. The safety profile of favipiravir in COVID-19 patients with severe renal impairment

Selim Gök, Ömer Faruk Bahçecioğlu, Mefküre Durmuş, Zeynep Ülkü Gün, Yasemin Ersoy, Zeynep Ayfer Aytemur, Özkan Ulutaş

International Journal of Clinical Practice

First published: 03 October 2021.

https://onlinelibrary.wiley.com/doi/epdf/10.1111/ijcp.14938

 

9.  Outcomes of Tocilizumab Therapy in Severe or Critical COVID-19 Patients: A Retrospective Cohort, Single-Center Study

Hassan Abdelnaby, Wael Aboelhassan, Mohammed Al-Jarallah, Rajesh Rajan, Raja Dashti, Ahmad R. Al Saber, Ahmed Abd el-Saleem, Islam Ashri, Mohammed Abdullah, Ahmed Mahmud Fouad

Tropical Medicine & International Health

First published: 03 October 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1111/tmi.13685

 

10. Characterization of SARS-CoV-2 and common cold coronavirus-specific T cell responses in MIS-C and Kawasaki disease children

Li-En Hsieh, Alba Grifoni, John Sidney, Chisato Shimizu, Hiroko Shike, Nanda Ramchandar, Elizabeth Moreno, Adriana H. Tremoulet, Jane C. Burns, Alessandra Franco

European Journal of Immunology

First published: 02 October 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.202149556

 

11. Establishing an internal quality control method for the stable extraction of nucleic acids of severe acute respiratory syndrome coronavirus 2 and RT-PCR-based detection

Takahiro Okuyama, Kouki Ohtsuka, Wataru Ogura, Shota Yonetani, Satoko Yamasaki, Hiroyuki Miyagi, Kumiko Sekiguchi, Hiroaki Ohnishi, Takashi Watanabe

Journal of Clinical Laboratory Analysis

First published: 02 October 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcla.23998

 

12. Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections

Rita Gaspari, Giorgia Spinazzola, Luciana Teofili, Alfonso W. Avolio, Barbara Fiori, Gianmarco Maresca, Teresa Spanu, Nicola Nicolotti, Gennaro De Pascale, Massimo Antonelli

European Journal of Clinical Investigation

First published: 02 October 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1111/eci.13687

 

13. SARS-CoV-2 Alpha, Beta and Delta variants display enhanced Spike-mediated Syncytia Formation

Maaran Michael Rajah, Mathieu Hubert, Elodie Bishop, Nell Saunders, Remy Robinot, Ludivine Grzelak, Delphine Planas, Jérémy Dufloo, Stacy Gellenoncourt, Alice Bongers, Marija Zivaljic, Cyril Planchais, Florence Guivel-Benhassine, Françoise Porrot, Hugo Mouquet, Lisa A Chakrabarti, Julian Buchrieser, Olivier Schwartz

The EMBO Journal

https://www.embopress.org/doi/epdf/10.15252/embj.2021108944

 

14. Turn up the lights, leave them on, and shine them all around ‐ numerical simulations point the way to more efficient use of Far‐UVC lights for the inactivation of airborne coronavirus

Kenneth Wood, Andrew Wood, Camilo Peñaloza, Ewan Eadie

Photochemistry and Photobiology

First published: 02 October 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1111/php.13523

 

15. The effect of COVID‐19 on patients with chronic spontaneous urticaria treated with omalizumab and antihistamines: A cross‐sectional, comparative study

Ecem Bostan MD, Fethi Zaid MD, Aysen Karaduman MD, Sibel Dogan MD, Duygu Gulseren MD, Basak Yalici-Armagan MD, Neslihan Akdogan MD, Sibel Ersoy-Evans MD, Gonca Elcin MD

Journal of Cosmetic Dermatology

First published: 02 October 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1111/jocd.14484

 

Các công bố về COVID-19 trước thời gian trên:

 

Cập nhật các công bố về COVID-19 từ ngày 24/09 đến ngày 01/10/2021

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-24-9-den-ngay-01-10-2021-4058.html

 

Cập nhật các công bố về COVID-19 từ ngày 17/09 đến ngày 24/09/2021

https://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-17-9-den-24-9-2021-4028.html

 

Cập nhật các công bố về COVID-19 từ ngày 10/09 đến ngày 17/09/2021

https://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-10-9-den-ngay-17-9-2021-4002.html

 

Cập nhật các công bố về COVID-19 từ ngày 27/08 đến ngày 03/09/2021

https://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-27-8-den-ngay-3-9-2021-3953.html

 

Cập nhật các công bố về COVID-19 từ ngày 20/08 đến ngày 27/08/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-20-8-den-ngay-27-8-2021-3932.html

 

Cập nhật các công bố về COVID-19 từ ngày 13/08 đến ngày 20/08/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-13-8-den-ngay-20-8-2021-3904.html

Cập nhật các công bố về COVID-19 từ ngày 06/08 đến ngày 13/08/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-6-8-den-ngay-13-8-2021-3878.html

 

Cập nhật các công bố về COVID-19 từ ngày 30/07 đến ngày 06/08/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-30-7-den-ngay-6-8-2021-3849.html

 

Cập nhật các công bố về COVID-19 từ ngày 23/07 đến ngày 30/07/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-23-7-den-ngay-30-7-2021-3823.html

 

Cập nhật các công bố về COVID-19 từ ngày 16/07 đến ngày 23/07/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-16-07-den-ngay-23-07-2021-3797.html

 

Cập nhật các công bố về COVID-19 từ ngày 09/07 đến ngày 16/07/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-07-den-ngay-16-07-2021-3769.html

 

Cập nhật các công bố về COVID-19 từ ngày 02/07 đến ngày 09/07/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-02-7-2021-den-ngay-9-7-2021-3744.html

 

Cập nhật các công bố về COVID-19 từ ngày 25/06 đến ngày 02/07/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-25-6-den-ngay-02-7-2021-3716.html

 

Cập nhật các công bố về COVID-19 từ ngày 18/06 đến ngày 25/06/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-18-6-den-ngay-25-6-2021-3692.html

 

Cập nhật các công bố về COVID-19 từ ngày 11/06 đến ngày 18/06/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-11-06-den-ngay-18-06-2021-3663.html

 

Cập nhật các công bố về COVID-19 từ ngày 04/06 đến ngày 11/06/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-04-06-den-ngay-11-6-2021-3642.html

 

Cập nhật các công bố về COVID-19 từ ngày 28/05 đến ngày 04/06/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-28-05-den-ngay-04-06-2021-3624.html

 

Cập nhật các công bố về COVID-19 từ ngày 21/05 đến ngày 28/05/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-21-05-den-ngay-28-05-2021-3598.html

 

Cập nhật các công bố về COVID-19 từ ngày 14/05 đến ngày 21/05/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-14-05-den-ngay-21-05-2021-3582.html

 

Cập nhật các công bố về COVID-19 từ ngày 07/05 đến ngày 14/05/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-07-05-den-ngay-14-05-2021-3557.html

Cập nhật các công bố về COVID-19 từ ngày 30/04 đến ngày 07/05/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-30-04-den-ngay-07-05-2021-3530.html

 

Cập nhật các công bố về COVID-19 từ ngày 23/04 đến ngày 30/04/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-23-04-den-ngay-30-04-2021-3509.html

 

Cập nhật các công bố về COVID-19 từ ngày 16/04 đến ngày 23/04/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-16-04-den-ngay-23-04-2021-3484.html

 

Cập nhật các công bố về COVID-19 từ ngày 09/04 đến ngày 16/04/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-04-den-ngay-19-04-2021-3474.html

 

Cập nhật các công bố về COVID-19 từ ngày 02/04 đến ngày 09/04/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-02-04-den-ngay-09-04-2021-3432.html

 

Cập nhật các công bố về COVID-19 từ ngày 26/03 đến ngày 02/04/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-26-03-den-ngay-02-04-2021-3408.html

 

Cập nhật các công bố về COVID-19 từ ngày 19/03 đến ngày 26/03/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-19-03-den-ngay-26-03-2021-3386.html

 

Cập nhật các công bố về COVID-19 từ ngày 12/03 đến ngày 19/03/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-12-3-den-ngay-19-3-2021-3376.html

 

Cập nhật các công bố về COVID-19 từ ngày 26/02 đến ngày 04/03/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-26-02-den-ngay-4-3-2021-3336.html

 

Cập nhật các công bố về COVID-19 từ ngày 09/02 đến ngày 25/02/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-02-den-ngay-25-02-2021-3319.html

 

Cập nhật các công bố về COVID-19 từ ngày 23/01 đến ngày 29/01/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-23-01-den-ngay-29-01-2021-3250.html

 

Cập nhật các công bố về COVID-19 từ ngày 09/01 đến ngày 15/01/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-01-den-ngay-15-01-2021-3211.html

 

Cập nhật các công bố về COVID-19 từ ngày 18/12 đến ngày 24/12/2020

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-18-12-den-ngay-24-12-2020-3174.html

Cập nhật các công bố về COVID-19 từ ngày 05/12 đến ngày 17/12/2020

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-05-12-den-ngay-17-12-2020-3160.html

 

Cập nhật các công bố về COVID-19 từ ngày 15/11 đến ngày 22/11/2020

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-11-den-ngay-22-11-2020-3123.html

 

Cập nhật các công bố về COVID-19 từ ngày 02/10 đến ngày 09/11/2020

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-02-10-den-ngay-09-11-2020-3107.html

 

Cập nhật các công bố về COVID-19 từ ngày 26/9 đến ngày 02/10/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-26-9-den-ngay-02-10-2020-3027.html

 

Cập nhật các công bố về COVID-19 từ ngày 19/9 đến ngày 25/9/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-19-9-den-ngay-25-9-2020-3010.html

 

Cập nhật các công bố về COVID-19 từ ngày 05/9 đến ngày 11/9/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-05-9-den-ngay-11-9-2020-2969.html

 

Cập nhật các công bố về COVID-19 từ ngày 29/8 đến ngày 04/9/2020

http://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-29-8-den-ngay-04-9-2020-2944.html

 

Cập nhật các công bố về COVID-19 từ ngày 21/8 đến ngày 28/8/2020

http://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-21-8-den-ngay-28-8-2020-2929.html

 

Cập nhật các công bố về VACCINE COVID-19 tháng 8 năm 2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-vaccine-covid-19-2900.html

 

Cập nhật các công bố về COVID-19 từ ngày 08/8 đến ngày 14/8/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-08-8-den-ngay-14-8-2020-2866.html

 

Cập nhật các công bố về COVID-19 từ ngày 27/7 đến ngày 07/8/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-27-7-den-ngay-07-8-2020-2826.html

 

Cập nhật các công bố về COVID-19 từ ngày 15/7 đến ngày 26/7/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-7-den-ngay-26-7-2020-2779.html

 

Cập nhật các công bố về COVID-19 từ ngày 05/7 đến ngày 13/7/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-05-7-den-ngay-13-7-2020-2723.html

 

Cập nhật các công bố về COVID-19 từ ngày 22/6 đến ngày 30/6/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-22-6-den-ngay-30-6-2020-2681.html

 

Cập nhật các công bố về COVID-19 từ ngày 15/6 đến ngày 21/6/2020

https://www.most.gov.vn/vn/tin-tuc/17959/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-6-den-ngay-21-6-2020.aspx

 

Cập nhật các công bố về COVID-19 từ ngày 07/6 đến ngày 14/6/2020

http://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-07-6-den-ngay-14-6-2020-2580.html

 

Cập nhật các công bố về COVID-19 đến ngày 07/6/2020

http://www.vista.gov.vn/news/khoa-hoc-ky-thuat-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-01-6-den-ngay-07-6-2020-2553.html

 

Cập nhật các công bố về COVID-19 đến ngày 01/6/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-den-ngay-01-6-2020-2524.html

 

Cập nhật các công bố về COVID-19 từ ngày 15/5 tới ngày 21/5/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-5-den-ngay-24-5-2020-2478.html

 

Cập nhật các công bố về COVID-19 từ ngày 08/5 tới ngày 14/5/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-08-5-den-ngay-14-5-2020-2436.html

 

Cập nhật các công bố về COVID-19 từ ngày 30/4 tới ngày 07/5/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-30-4-den-ngay-07-5-2020-2406.html

 

Cập nhật các công bố về COVID-19 từ ngày 24/4 tới ngày 30/4/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-24-4-den-ngay-30-4-2020-2375.html

 

Cập nhật các công bố về COVID-19 từ ngày 17/4 tới ngày 23/4/2020

https://www.most.gov.vn/vn/tin-tuc/17695/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-17-4-den-ngay-23-4-2020.aspx

 

Cập nhật các công bố về COVID-19 từ ngày 10/4 tới ngày 16/4/2020

https://www.most.gov.vn/vn/tin-tuc/17655/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-10-4--den-ngay-16-4-2020.aspx

 

Cập nhật các công bố về COVID-19 từ ngày 03/4 tới ngày 09/4/2020

https://www.most.gov.vn/vn/tin-tuc/17630/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-3-4--den-ngay-9-4-2020.aspx

 

Cập nhật các công bố về COVID-19 từ ngày 27/3 tới ngày 02/4/2020

https://www.most.gov.vn/vn/tin-tuc/17609/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-27-3-den-ngay-02-4-2020.aspx

 

Cập nhật các công bố về COVID-19 từ ngày 20/3 tới ngày 26/3/2020

https://www.most.gov.vn/vn/tin-tuc/17597/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-20-3-den-ngay-26-3-2020.aspx

 

Cập nhật các công bố về COVID-19 từ ngày 13/3 tới ngày 19/3/2020

https://www.most.gov.vn/vn/tin-tuc/17575/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-13-3-den-ngay-19-3-2020.aspx

 

Cập nhật các công bố về COVID-19 từ ngày 06/3 tới ngày 12/3/2020

https://www.most.gov.vn/vn/tin-tuc/17547/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-06-3-den-ngay-12-3-2020.aspx

 

Cập nhật các công bố về COVID-19 từ ngày 28/02 tới ngày 05/3/2020

http://www.vista.gov.vn/UserPages/News/detail/tabid/73/newsid/20781/language/vi-VN/Default.aspx?seo=Cap-nhat-cac-cong-bo-moi-ve-COVID-19-den-ngay-05/3/2020&language=vi-VN

 

Cập nhật các công bố về COVID-19 từ ngày 11/02 tới ngày 27/02/2020

http://www.vista.gov.vn/UserPages/News/detail/tabid/73/newsid/20740/seo/20740/language/vi-VN/language/vi-VN/Default.aspx

 

Cập nhật các công bố về virus corona từ tháng 11/2019 tới ngày 10/02/2020 

http://www.vista.gov.vn/UserPages/News/detail/tabid/73/newsid/20678/seo/20678/language/vi-VN/Default.aspx

 

Nguồn: Cục Thông tin KH&CN quốc gia

Lượt xem: 1547

Tìm theo ngày :

Đánh giá

(Di chuột vào ngôi sao để chọn điểm)